All Type of News
Pharmas to enjoy 10 days of holiday this October
While the government designated the 2nd of October as a temporary holiday, pharmaceutical companies are expected to enjoy 10 days of holiday this October.
Yakup Shinmoon checked plans for the 2nd of October on major ...
Hanmi Pharm ranked the top in ratio of doctors having experience of prescribing the company’s product within a month
A survey on doctors showed Yuhan Corporation, the top sales pharmaceutical company last year, was ranked the top in positive sections, such as ethicality, R&D and reliability, and Hanmi Pharm was chosen a pharmaceutic...
Celgene Korea appoints Tae-Jin Ham as new CEO
Celgene Korea announced appointment of Tae-Jin Ham, a new CEO, from the 1st of September.
CEO Tae-Jin Ham joined in Celgene in 2015 and continued to hold multiple positions, such as a head of the Asia region strategy...
Reevaluation period for advanced medical devices changes from 4 to 5 years
The government will relax regulations about medical devices, such as shortening the current reevaluation period for advanced medical devices from 4 years to 5 years.
The Ministry of Food and Drug Safety gave an admin...
Pharmaceutical distribution companies expanding sales and marketing activities to consumers over ‘doctors and pharmacists’
Pharmaceutical distribution companies which has focused their sale and marketing business on pharmacies, hospitals and clinics have actively jumped into searching connections with consumers.
So far, pharmaceutical di...
7 of 11 biosimilars approved in Korea were developed by Korean company
It was reported there were the total 11 biosimilar products approved in Korea, such as ‘Remsima 100mg,’ and 7 of them were developed by Korean pharmaceutical companies.
According to the Ministry of Food and Drug Safe...
CKD & MSD Korea adopt VR marketing program for ‘Januvia’
Chong Kun Dang(CEO Young-Joo Kim, CKD) and MSD Korea(CEO Avi BenShoshan) announced on the 6th that they implemented ‘Januvia VR Detail,’ a virtual reality(VR) program, in the field of the antidiabetic ‘Januvia’ busine...
CJ HealthCare applies new drug approval of acid reflex treatment
The CJ HealthCare’s first new medicine, an acid reflux treatment, has taken a approval process in Korea its launch.
CJ HealthCare(CEO Seok-Hee Kang) announced on the 4th that it applied product approval of ‘tegopraza...
Will the Pangyo era come with R&D center for small & medium pharmas?
Korea Pharmaceutical Ind. Coop. Chairman Yong-Jun Cho visited the Gyeonggi Provincial Government in the afternoon of the 4th and exchanged various opinions about small and medium pharmaceutical companies’ future direc...
ISU Abxis, Celltrion Bukwang record highest R&D/sales ratio in order
While KOSPI listed pharmaceutical companies had narrowly enlarged R&D expenses in the 1st half of this year compared to the same period of the last year, KOSDAQ listed pharmaceutical companies stayed the same in the i...
